Smart & START ITALIA — KERUBIN S.R.L. S.B. (Q4149881): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in es, and other parts: Adding Spanish translations) |
(Changed label, description and/or aliases in en, and other parts: Adding English translations) |
||||||||||||||
| label / en | label / en | ||||||||||||||
Smart & START ITALIA — KERUBIN S.R.L. S.B. | |||||||||||||||
| Property / summary | |||||||||||||||
THE KERUBIN DEVICE CURRENTLY CONSISTS OF A PLATFORM FOR CANCER CARE AND THE RELATED APP AIMED AT THE PATIENT, ABLE TO SELF-REPORTING TO RECOGNISE AND GRADATE ADVERSE EVENTS. (English) | |||||||||||||||
| Property / summary: THE KERUBIN DEVICE CURRENTLY CONSISTS OF A PLATFORM FOR CANCER CARE AND THE RELATED APP AIMED AT THE PATIENT, ABLE TO SELF-REPORTING TO RECOGNISE AND GRADATE ADVERSE EVENTS. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: THE KERUBIN DEVICE CURRENTLY CONSISTS OF A PLATFORM FOR CANCER CARE AND THE RELATED APP AIMED AT THE PATIENT, ABLE TO SELF-REPORTING TO RECOGNISE AND GRADATE ADVERSE EVENTS. (English) / qualifier | |||||||||||||||
point in time: 31 January 2022
| |||||||||||||||
Revision as of 11:01, 31 January 2022
Project Q4149881 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Smart & START ITALIA — KERUBIN S.R.L. S.B. |
Project Q4149881 in Italy |
Statements
377,248.74 Euro
0 references
138,512.1 Euro
0 references
272.36 percent
0 references
KERUBIN S.R.L. S.B.
0 references
IL DISPOSITIVO KERUBIN ATTUALMENTE SI COMPONE DI UNA PIATTAFORMA PER L'ASSISTENZA ONCOLOGICA E DELLA RELATIVA APP RIVOLTA AL PAZIENTE, IN GRADO IN SELF-REPORTING DI RICONOSCERE E GRADARE EVENTI AVVERSI. (Italian)
0 references
EL DISPOSITIVO KERUBIN CONSISTE ACTUALMENTE EN UNA PLATAFORMA PARA EL CUIDADO DEL CÁNCER Y LA APLICACIÓN RELACIONADA DIRIGIDA AL PACIENTE, CAPAZ DE AUTO-REPORTAR PARA RECONOCER Y GRADUAR EVENTOS ADVERSOS. (Spanish)
30 January 2022
0 references
THE KERUBIN DEVICE CURRENTLY CONSISTS OF A PLATFORM FOR CANCER CARE AND THE RELATED APP AIMED AT THE PATIENT, ABLE TO SELF-REPORTING TO RECOGNISE AND GRADATE ADVERSE EVENTS. (English)
31 January 2022
0 references
MASSA LUBRENSE
0 references